Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
Adv Exp Med Biol ; 963: 1-12, 2017.
Article in English | MEDLINE | ID: mdl-28197903

ABSTRACT

Reversible post-translational modification is a rapid and efficient system to control the activity of pre-existing proteins. Modifiers range from small chemical moieties, such as phosphate groups, to proteins themselves as the modifier. The patriarch of the protein modifiers is ubiquitin which plays a central role in protein degradation and protein targeting. Over the last 20 years, the ubiquitin family has expanded to include a variety of ubiquitin-related small modifier proteins that are all covalently attached to a lysine residue on target proteins via series of enzymatic reactions. Of these more recently discovered ubiquitin-like proteins, the SUMO family has gained prominence as a major regulatory component that impacts numerous aspects of cell growth, differentiation, and response to stress. Unlike ubiquitinylation which often leads to proteins turn over, sumoylation performs a variety of function such as altering protein stability, modulating protein trafficking, directing protein-protein interactions, and regulating protein activity. This chapter will introduce the basic properties of SUMO proteins and the general tenets of sumoylation.


Subject(s)
Small Ubiquitin-Related Modifier Proteins/metabolism , Sumoylation , Animals , Humans , Lysine , Protein Conformation , Protein Stability , Protein Transport , Signal Transduction , Small Ubiquitin-Related Modifier Proteins/chemistry , Structure-Activity Relationship
2.
Adv Exp Med Biol ; 963: 197-214, 2017.
Article in English | MEDLINE | ID: mdl-28197914

ABSTRACT

Tissue morphogenesis is a fascinating aspect of both developmental biology and regeneration of certain adult organs, and timely control of cellular differentiation is a key to these processes. During development, events interrupting cellular differentiation and leading to organ failure are embryonic lethal; likewise, perturbation of differentiation in regenerating tissues leads to dysfunction and disease. At the molecular level, cellular differentiation is orchestrated by a well-coordinated cascade of transcription factors (TFs) and chromatin remodeling complexes that drive gene expression. Altering the localization, stability, or activity of these regulatory elements can affect the sequential organization of the gene expression program and result in failed or abnormal tissue development. An accumulating body of evidence shows that the sumoylation system is a critical modulator of these regulatory cascades. For example, inhibition of the sumoylation system during embryogenesis causes lethality and/or severe abnormalities from invertebrates to mammals. Mechanistically, it is now known that many of the TFs and components of chromatin remodeling complexes that are critical for development and differentiation are targets for SUMO modification, though the specific functional consequences of the modifications remain uncharacterized in many cases. This chapter will address several of the models systems that have been examined for the role of sumoylation in differentiation and development. Understanding the profound regulatory role of SUMO in different tissues should lead not only to a better understanding of developmental biology, stem cell linage control, and the mechanisms of cellular differentiation, but may also lead to the identification of new targets for drug therapy and/or therapeutic manipulation of damaged organs and tissues.


Subject(s)
Cell Differentiation , Signal Transduction , Small Ubiquitin-Related Modifier Proteins/metabolism , Stem Cells/metabolism , Sumoylation , Ubiquitin-Protein Ligases/metabolism , Animals , Cell Lineage , Chromatin Assembly and Disassembly , Female , Gene Expression Regulation, Developmental , Humans , Male , Morphogenesis , Phenotype
3.
Adv Exp Med Biol ; 963: 359-388, 2017.
Article in English | MEDLINE | ID: mdl-28197923

ABSTRACT

Viruses have evolved elaborate means to regulate diverse cellular pathways in order to create a cellular environment that facilitates viral survival and reproduction. This includes enhancing viral macromolecular synthesis and assembly, as well as preventing antiviral responses, including intrinsic, innate, and adaptive immunity. There are numerous mechanisms by which viruses mediate their effects on the host cell, and this includes targeting various cellular post-translational modification systems, including sumoylation. The wide-ranging impact of sumoylation on cellular processes such as transcriptional regulation, apoptosis, stress response, and cell cycle control makes it an attractive target for viral dysregulation. To date, proteins from both RNA and DNA virus families have been shown to be modified by SUMO conjugation, and this modification appears critical for viral protein function. More interestingly, members of the several viral families have been shown to modulate sumoylation, including papillomaviruses, adenoviruses , herpesviruses, orthomyxoviruses, filoviruses , and picornaviruses . This chapter will focus on mechanisms by which sumoylation both impacts human viruses and is used by viruses to promote viral infection and disease.


Subject(s)
DNA Viruses/metabolism , RNA Viruses/metabolism , Signal Transduction , Small Ubiquitin-Related Modifier Proteins/metabolism , Sumoylation , Ubiquitin-Protein Ligases/metabolism , Viral Proteins/metabolism , Virus Diseases/metabolism , Animals , DNA Viruses/genetics , DNA Viruses/pathogenicity , Gene Expression Regulation, Viral , Host-Pathogen Interactions , Humans , RNA Viruses/genetics , RNA Viruses/pathogenicity , Viral Proteins/genetics , Virus Diseases/genetics , Virus Diseases/virology
4.
Viruses ; 6(9): 3584-611, 2014 Sep 24.
Article in English | MEDLINE | ID: mdl-25254385

ABSTRACT

Human papillomaviruses (HPVs) are small DNA viruses that are important etiological agents of a spectrum of human skin lesions from benign to malignant. Because of their limited genome coding capacity they express only a small number of proteins, only one of which has enzymatic activity. Additionally, the HPV productive life cycle is intimately tied to the epithelial differentiation program and they must replicate in what are normally non-replicative cells, thus, these viruses must reprogram the cellular environment to achieve viral reproduction. Because of these limitations and needs, the viral proteins have evolved to co-opt cellular processes primarily through protein-protein interactions with critical host proteins. The ubiquitin post-translational modification system and the related ubiquitin-like modifiers constitute a widespread cellular regulatory network that controls the levels and functions of thousands of proteins, making these systems an attractive target for viral manipulation. This review describes the interactions between HPVs and the ubiquitin family of modifiers, both to regulate the viral proteins themselves and to remodel the host cell to facilitate viral survival and reproduction.


Subject(s)
Papillomaviridae/physiology , Protein Processing, Post-Translational , Ubiquitin/metabolism , Animals , Host-Pathogen Interactions , Humans , Papillomavirus Infections/metabolism , Proteasome Endopeptidase Complex/metabolism , Protein Binding , Viral Proteins/metabolism , Virus Replication
5.
Methods Mol Biol ; 1195: 33-41, 2014.
Article in English | MEDLINE | ID: mdl-24155234

ABSTRACT

HaCaT cells are a spontaneously immortalized, human keratinocyte line that has been widely used for studies of skin biology and differentiation. Under typical culture conditions HaCaT cells have a partially to fully differentiated phenotype due to the high calcium content of both standard media and fetal bovine serum. This chapter describes low-calcium culture conditions for reverting HaCaT cells to the fully basal state followed by subsequent controlled differentiation using calcium induction.


Subject(s)
Cell Culture Techniques/methods , Cell Differentiation , Keratinocytes/cytology , Calcium/pharmacology , Cell Differentiation/drug effects , Cell Line , Cell Proliferation/drug effects , Humans , Keratinocytes/drug effects , Phenotype
6.
PLoS One ; 7(1): e30165, 2012.
Article in English | MEDLINE | ID: mdl-22291911

ABSTRACT

Sumoylation is a highly dynamic process that plays a role in a multitude of processes ranging from cell cycle progression to mRNA processing and cancer. A previous study from our lab demonstrated that SUMO plays an important role in keratinocyte differentiation. Here we present a new method of tracking the sumoylation state of proteins by creating a stably transfected HaCaT keratinocyte cell line expressing an inducible SNAP-SUMO3 protein. The SNAP-tag allows covalent fluorescent labeling that is denaturation resistant. When combined with two-dimensional gel electrophoresis, the SNAP-tag technology provides direct visualization of sumoylated targets and can be used to follow temporal changes in the global cohort of sumoylated proteins during dynamic processes such as differentiation. HaCaT keratinocyte cells expressing SNAP-SUMO3 displayed normal morphological and biochemical features that are consistent with typical keratinocyte differentiation. SNAP-SUMO3 also localized normally in these cells with a predominantly nuclear signal and some minor cytoplasmic staining, consistent with previous reports for untagged SUMO2/3. During keratinocyte differentiation the total number of proteins modified by SNAP-SUMO3 was highest in basal cells, decreased abruptly after induction of differentiation, and slowly rebounded beginning between 48 and 72 hours as differentiation progressed. However, within this overall trend the pattern of change for individual sumoylated proteins was highly variable with both increases and decreases in amount over time. From these results we conclude that sumoylation of proteins during keratinocyte differentiation is a complex process which likely reflects and contributes to the biochemical changes that drive differentiation.


Subject(s)
Cell Differentiation , Keratinocytes/physiology , Small Ubiquitin-Related Modifier Proteins/metabolism , Sumoylation , Algorithms , Amino Acid Sequence , Cell Cycle/genetics , Cell Differentiation/genetics , Cells, Cultured , HEK293 Cells , Humans , Keratinocytes/metabolism , Metabolome , Models, Biological , Molecular Sequence Data , Protein Processing, Post-Translational/genetics , Protein Processing, Post-Translational/physiology , Small Ubiquitin-Related Modifier Proteins/genetics , Sumoylation/genetics , Sumoylation/physiology , Transfection , Ubiquitins/genetics , Ubiquitins/metabolism , Validation Studies as Topic
7.
Curr Protoc Microbiol ; Chapter 14: Unit14B.1, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22307550

ABSTRACT

This unit contains protocols for evaluation of replication functionality of papillomavirus genomes or subgenomic fragments. Replication is measured after transient cotransfection of the genome (or subgenomic fragment) with expression vectors encoding the viral E1 and E2 proteins. Input DNA is methylated at the adenine of GATC sequences by propagation in E. coli. DNA that replicates in mammalian cells will lose the adenine methylation and become DpnI-resistant, while residual methylated input DNA will remain DpnI-sensitive. After transfection, DNA extraction, and DpnI digestion, replicated DNA can be detected by Southern blotting as a full-length plasmid, since it is resistant to digestion. This assay can be used to map the genomic location of a functional origin or to evaluate replication activity of mutations in either the origin DNA sequences or the E1 or E2 proteins.


Subject(s)
Papillomaviridae/physiology , Virus Replication , Animals , Blotting, Southern , Cell Culture Techniques , DNA Methylation , DNA, Viral/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Humans , Papillomaviridae/growth & development , Papillomaviridae/pathogenicity , Plasmids , Transfection
8.
Biomolecules ; 2(2): 203-27, 2012 Apr 05.
Article in English | MEDLINE | ID: mdl-23795346

ABSTRACT

Many viral proteins have been shown to be sumoylated with corresponding regulatory effects on their protein function, indicating that this host cell modification process is widely exploited by viral pathogens to control viral activity. In addition to using sumoylation to regulate their own proteins, several viral pathogens have been shown to modulate overall host sumoylation levels. Given the large number of cellular targets for SUMO addition and the breadth of critical cellular processes that are regulated via sumoylation, viral modulation of overall sumoylation presumably alters the cellular environment to ensure that it is favorable for viral reproduction and/or persistence. Like some viruses, certain bacterial plant pathogens also target the sumoylation system, usually decreasing sumoylation to disrupt host anti-pathogen responses. The recent demonstration that Listeria monocytogenes also disrupts host sumoylation, and that this is required for efficient infection, extends the plant pathogen observations to a human pathogen and suggests that pathogen modulation of host sumoylation may be more widespread than previously appreciated. This review will focus on recent aspects of how pathogens modulate the host sumoylation system and how this benefits the pathogen.

9.
Virus Res ; 158(1-2): 199-208, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21510985

ABSTRACT

The human papillomavirus oncogenic protein, E6, interacts with a number of cellular proteins, and for some targets, E6 directs their degradation through the ubiquitin-proteasome pathway. Post-translational modification with ubiquitin-like modifiers, such as SUMO, also influences protein activities, protein-protein interactions, and protein stability. We report that the high risk HPVE6 proteins reduce the intracellular quantity of the sole SUMO conjugation enzyme, Ubc9, concomitant with decreased host sumoylation. E6 did not significantly influence transcription of Ubc9, indicating that the effects were likely at the protein level. Consistent with typical E6-mediated proteasomal degradation, E6 bound to Ubc9 in vitro, and required E6AP for reduction of Ubc9 levels. Under stable E6 expression conditions in differentiating keratinocytes there was a decrease in Ubc9 and a loss of numerous sumoylated targets indicating a significant perturbation of the normal sumoylation profile. While E6 is known to inhibit PIASy, a SUMO ligase, our results suggest that HPV E6 also targets the Ubc9 protein to modulate host cell sumoylation, suggesting that the sumoylation system may be an important target during viral reproduction and possibly the subsequent development of cervical cancer.


Subject(s)
Oncogene Proteins, Viral/metabolism , Papillomaviridae/pathogenicity , Repressor Proteins/metabolism , Ubiquitin-Conjugating Enzymes/antagonists & inhibitors , Cell Line , DNA-Binding Proteins , Humans , Keratinocytes/virology , Protein Binding , Protein Interaction Mapping , Transcription, Genetic , Virulence Factors/metabolism
10.
Virus Res ; 150(1-2): 135-7, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20193720

ABSTRACT

Papillomaviruses infect keratinocytes and their reproduction is tied to differentiation of the skin. The E2 protein of papillomaviruses is a multifunctional early protein that binds specifically to the viral DNA to regulate genome transcription, replication, and segregation. All of these are nuclear events that require specific transport of E2 into the host nucleus. Nuclear localization signal (NLS) sequences have been mapped for several E2 proteins, and these sequences resemble motifs that interact with cellular transport adaptor molecules termed alpha importins. To determine which importins could carry E2 proteins, in vitro binding studies were performed with three different E2 proteins and the five ubiquitous alpha importins. The E2 proteins preferentially interacted with alpha importins 3 and 5, and showed very weak or no interaction with the other three widely expressed alpha importins (alpha1, alpha 4, and alpha 7). While all five alpha importins appear to be constitutively expressed in keratinocytes, during differentiation of a human keratinocyte line (HaCaT) we observed a specific increase in expression of alphas 3 and 5. This differentiation-specific increase in alpha 3 and alpha 5 expression suggests that preferential usage of these two importins by E2 may facilitate E2 nuclear uptake during terminal differentiation.


Subject(s)
DNA-Binding Proteins/metabolism , Oncogene Proteins, Viral/metabolism , Viral Proteins/metabolism , alpha Karyopherins/metabolism , Cell Line , Humans , Protein Binding
11.
Mol Biol Rep ; 37(3): 1155-63, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19242820

ABSTRACT

Regulation of the sumoylation system at the level of gene expression has not yet been explored. To begin to define transcriptional regulatory features, the promoter region for the SUMO1 gene was cloned from human genomic DNA and characterized. Initially, a 532 base pair fragment upstream of and including the predicted SUMO1 transcription start site (TSS) was cloned and shown to possess promoter activity. Subsequent deletion analysis showed that a smaller fragment containing 158 bp upstream of the TSS region exhibited basal promoter activity in both human and rodent cell lines. Within this basal promoter fragment, there were predicted binding sites for numerous transcription factors, including the nude mouse gene product, Whn (FoxN1). Electrophoretic mobility shift assays showed that Whn could bind to an ACGC motif adjacent to the TSR, and in transfection studies Whn stimulated a 3-fold increase in transcription from this cloned promoter in keratinocytes (HaCaT cells). Mutation of the ACGC motif abrogated both Whn binding and transcriptional activation, indicating that the Whn effect is likely due to direct interaction with this promoter element. Consistent with these observations on the cloned promoter region, Whn also modestly stimulated transcription from the endogenous, genomic SUMO1 promoter in HaCaT cells, consistent with Whn potentially playing a regulatory role for SUMO1 transcription in keratinocytes.


Subject(s)
Gene Expression Regulation/genetics , Promoter Regions, Genetic/genetics , SUMO-1 Protein/genetics , Animals , Base Sequence , Binding Sites/genetics , Cell Line , Cloning, Molecular , DNA Primers/genetics , Electrophoretic Mobility Shift Assay , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/metabolism , Humans , Keratinocytes/metabolism , Mice , Molecular Sequence Data , Mutation/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
12.
Virology ; 387(1): 176-83, 2009 Apr 25.
Article in English | MEDLINE | ID: mdl-19251296

ABSTRACT

The stability of papillomavirus E2 proteins is regulated by proteasomal degradation, and regulation of degradation could contribute to the higher expression levels of E2 proteins observed in suprabasal layers of differentiated skin. We have recently shown that the E2 proteins are modified by sumoylation [Wu Y-C, Roark AA, Bian X-L, Wilson, VG (2008) Virol 378:329-338], and that sumoylation levels are up-regulated during keratinocyte differentiation [Deyrieux AF, Rosas-Acosta G, Ozbun MA, Wilson VG (2007) J Cell Sci 120:125-136]. These observations, coupled with the known ability of sumoylation to prevent proteasomal degradation of certain proteins, suggested that this modification might contribute to stabilizing E2 proteins in suprabasal keratinocytes. Conditions that increased overall sumoylation were found to increase the intracellular amounts of the HPV11, 16, and 18 E2 proteins. No effect of sumoylation was seen on E2 transcripts, and the increased levels of E2 proteins resulted from a greatly increased half-life for the E2 proteins. In vitro studies confirmed that sumoylation could block the proteasomal degradation of the 16E2 protein. Interestingly, this stabilization effect was indirect as it did not require sumoylation of 16E2 itself and must be acting through sumoylation of a cellular target(s). This sumoylation-dependent, indirect stabilization of E2 proteins is a novel process that may couple E2 levels to changes in the cellular environment. Specifically, our results suggest that the levels of papillomavirus E2 protein could be up-regulated in differentiating keratinocytes in response to the increased overall sumoylation that accompanies differentiation.


Subject(s)
Papillomaviridae/metabolism , SUMO-1 Protein/metabolism , Viral Proteins/metabolism , Gene Expression Regulation, Viral/drug effects , HeLa Cells , Humans , Papillomaviridae/genetics , Proteasome Endopeptidase Complex/genetics , Proteasome Endopeptidase Complex/metabolism , Protein Processing, Post-Translational , Protein Stability , SUMO-1 Protein/pharmacology
13.
EMBO J ; 28(6): 711-24, 2009 Mar 18.
Article in English | MEDLINE | ID: mdl-19214191

ABSTRACT

Regulation of BCR signalling strength is crucial for B-cell development and function. Bright is a B-cell-restricted factor that complexes with Bruton's tyrosine kinase (Btk) and its substrate, transcription initiation factor-I (TFII-I), to activate immunoglobulin heavy chain gene transcription in the nucleus. Here we show that a palmitoylated pool of Bright is diverted to lipid rafts of resting B cells where it associates with signalosome components. After BCR ligation, Bright transiently interacts with sumoylation enzymes, blocks calcium flux and phosphorylation of Btk and TFII-I and is then discharged from lipid rafts as a Sumo-I-modified form. The resulting lipid raft concentration of Bright contributes to the signalling threshold of B cells, as their sensitivity to BCR stimulation decreases as the levels of Bright increase. Bright regulates signalling independent of its role in IgH transcription, as shown by specific dominant-negative titration of rafts-specific forms. This study identifies a BCR tuning mechanism in lipid rafts that is regulated by differential post-translational modification of a transcription factor with implications for B-cell tolerance and autoimmunity.


Subject(s)
Membrane Microdomains/metabolism , Receptors, Antigen, B-Cell/metabolism , Signal Transduction , Trans-Activators/metabolism , Transcription Factors/metabolism , Agammaglobulinaemia Tyrosine Kinase , Animals , Antigens/metabolism , B-Lymphocytes/enzymology , DNA-Binding Proteins , Humans , Immunoglobulin M/genetics , Immunoglobulin M/metabolism , Lipoylation , Lymphocyte Activation , Membrane Microdomains/enzymology , Mice , Mutation/genetics , Oncogenes , Phosphorylation , Protein Binding , Protein Transport , Protein-Tyrosine Kinases/metabolism , Small Ubiquitin-Related Modifier Proteins/metabolism , Transcription Factors, TFII/metabolism , Transcription, Genetic
14.
Virology ; 378(2): 329-38, 2008 Sep 01.
Article in English | MEDLINE | ID: mdl-18619639

ABSTRACT

Papillomavirus E2 proteins are critical regulatory proteins that function in replication, genome segregation, and viral transcription, including control of expression of the viral oncogenes, E6 and E7. Sumoylation is a post-translational modification that has been shown to target and modulate the function of many transcription factors, and we now demonstrate that E2 proteins are sumoylated. Both bovine and human papillomavirus E2 proteins bind to the SUMO conjugation enzyme, Ubc9, and using in vitro and E. coli sumoylation systems, these E2 proteins were readily modified by SUMO proteins. In vivo experiments further confirmed that E2 can be sumoylated by SUMO1, SUMO2, or SUMO3. Mapping studies identified lysine 292 as the principal residue for covalent conjugation of SUMO to HPV16 E2, and a lysine 292 to arginine mutant showed defects for both transcriptional activation and repression. The expression levels, intracellular localization, and the DNA-binding activity of HPV16 E2 were unchanged by this K292R mutation, suggesting that the transcriptional defect reflects a functional contribution by sumoylation at this residue. This study provides evidence that sumoylation has a role in the regulation of papillomavirus E2, and identifies a new mechanism for the modulation of E2 function at the post-translational level.


Subject(s)
DNA-Binding Proteins/metabolism , Oncogene Proteins, Viral/metabolism , Protein Processing, Post-Translational , SUMO-1 Protein/metabolism , Small Ubiquitin-Related Modifier Proteins/metabolism , Ubiquitins/metabolism , Viral Proteins/metabolism , Amino Acid Substitution/genetics , Animals , Cattle , Cell Line , DNA, Viral/metabolism , DNA-Binding Proteins/genetics , Gene Expression , Humans , Mutagenesis, Site-Directed , Mutation, Missense , Oncogene Proteins, Viral/genetics , Papillomaviridae/physiology , Protein Binding , Transcription, Genetic , Ubiquitin-Conjugating Enzymes/metabolism
15.
Expert Rev Proteomics ; 5(1): 121-35, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18282128

ABSTRACT

The small ubiquitin-like modifier proteins (Smt3 in yeast and SUMOs 1-4 in vertebrates) are members of the ubiquitin super family. Like ubiquitin, the SUMOs are protein modifiers that are covalently attached to the epsilon-amino group of lysine residues in the substrates. The application of proteomics to the SUMO field has greatly expanded both the number of known targets and the number of identified target lysines. As new refinements of proteomic techniques are developed and applied to sumoylation, an explosion of novel data is likely in the next 5 years. This ability to examine sumoylated proteins globally, rather than individually, will lead to new insights into both the functions of the individual SUMO types, and how dynamic changes in overall sumoylation occur in response to alterations in cellular environment. In addition, there is a growing appreciation for the existence of cross-talk mechanisms between the sumoylation and ubiquitinylation processes. Rather than being strictly parallel, these two systems have many points of intersection, and it is likely that the coordination of these two systems is a critical contributor to the regulation of many fundamental cellular events.


Subject(s)
Proteasome Endopeptidase Complex/metabolism , Protein Processing, Post-Translational/physiology , Proteomics/methods , Small Ubiquitin-Related Modifier Proteins/physiology , Ubiquitin/metabolism , Ubiquitination , Animals , Caenorhabditis elegans Proteins/metabolism , Conserved Sequence , Endopeptidases/metabolism , Humans , Ligases/physiology , Lysine/metabolism , Mass Spectrometry/methods , Mice , Models, Molecular , Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , Protein Array Analysis , Saccharomyces cerevisiae Proteins/metabolism , Two-Hybrid System Techniques , Ubiquitin-Protein Ligases/metabolism
16.
Virology ; 373(1): 149-62, 2008 Mar 30.
Article in English | MEDLINE | ID: mdl-18201744

ABSTRACT

Recent studies have demonstrated nuclear export by papillomavirus E1 proteins, but the requisite export sequence(s) for bovine papillomavirus (BPV) E1 were not defined. In this report we identify three functional nuclear export sequences (NES) present in BPV E1, with NES2 being the strongest in reporter assays. Nuclear localization of BPV1 E1 was modulated by over- or under-expression of CRM1, the major cellular exportin, and export was strongly reduced by the CRM1 inhibitor, Leptomycin B, indicating that E1 export occurs primarily through a CRM1-dependent process. Consistent with the in vivo functional results, E1 bound CRM1 in an in vitro pull-down assay. In addition, sumoylated E1 bound CRM1 more effectively than unmodified E1, suggesting that E1 export may be regulated by SUMO modification. Lastly, an E1 NES2 mutant accumulated in the nucleus to a greater extent than wild-type E1, yet was defective for viral origin replication in vivo. However, NES2 exhibited no intrinsic replication defect in an in vitro replication assay, implying that nucleocytoplasmic shuttling may be required to maintain E1 in a replication competent state.


Subject(s)
Active Transport, Cell Nucleus , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , Nuclear Export Signals/genetics , Viral Proteins/chemistry , Viral Proteins/metabolism , Amino Acid Sequence , Animals , Base Sequence , CHO Cells , COS Cells , Cattle , Cell Nucleus/metabolism , Chlorocebus aethiops , Cricetinae , Cricetulus , DNA-Binding Proteins/genetics , Gene Expression Regulation, Viral , HeLa Cells , Humans , Hydrophobic and Hydrophilic Interactions , Karyopherins/metabolism , Molecular Sequence Data , Nuclear Export Signals/physiology , Nuclear Localization Signals , Receptors, Cytoplasmic and Nuclear/metabolism , SUMO-1 Protein , Viral Proteins/genetics , Exportin 1 Protein
17.
J Virol Methods ; 139(2): 189-94, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17208312

ABSTRACT

Spodoptera frugiperda Sf9 cells were found to possess an active endogenous sumoylation system. However, the endogenous sumoylation machinery did not efficiently modify exogenous proteins expressed by infection with recombinant baculoviruses. To overcome this limitation, mammalian sumoylation components were introduced by co-infection with recombinant baculoviruses expressing individual protein components of the sumoylation pathway. Expression of mammalian Ubc9 plus SUMO (either SUMO1 or SUMO3) was necessary and sufficient for active sumoylation of co-infected test proteins. This system provides a simple and convenient means to produce sumoylated mammalian proteins in a eukaryotic environment. Large-scale cultures should provide quantities of sumoylated proteins sufficient for potential purification.


Subject(s)
SUMO-1 Protein/biosynthesis , Small Ubiquitin-Related Modifier Proteins/genetics , Spodoptera/virology , Animals , Baculoviridae/genetics , Cricetinae , Gene Expression , Genetic Vectors , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , SUMO-1 Protein/genetics , SUMO-1 Protein/metabolism , Small Ubiquitin-Related Modifier Proteins/metabolism
18.
J Cell Sci ; 120(Pt 1): 125-36, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17164289

ABSTRACT

SUMO modification regulates the activity of numerous transcription factors that have a direct role in cell-cycle progression, apoptosis, cellular proliferation, and development, but its role in differentiation processes is less clear. Keratinocyte differentiation requires the coordinated activation of a series of transcription factors, and as several crucial keratinocyte transcription factors are known to be SUMO substrates, we investigated the role of sumoylation in keratinocyte differentiation. In a human keratinocyte cell line model (HaCaT cells), Ca2+-induced differentiation led to the transient and coordinated transcriptional activation of the genes encoding crucial sumoylation system components, including SAE1, SAE2, Ubc9, SENP1, Miz-1 (PIASx beta), SUMO2 and SUMO3. The increased gene expression resulted in higher levels of the respective proteins and changes in the pattern of sumoylated substrate proteins during the differentiation process. Similarly to the HaCaT results, stratified human foreskin keratinocytes showed an upregulation of Ubc9 in the suprabasal layers. Abrogation of sumoylation by Gam1 expression severely disrupted normal HaCaT differentiation, consistent with an important role for sumoylation in the proper progression of this biological process.


Subject(s)
Keratinocytes/cytology , Keratinocytes/physiology , SUMO-1 Protein/metabolism , Small Ubiquitin-Related Modifier Proteins/metabolism , Ubiquitins/metabolism , Calcium/metabolism , Cell Differentiation/physiology , Cell Line , Gene Expression/physiology , Humans , SUMO-1 Protein/genetics , Skin/cytology , Small Ubiquitin-Related Modifier Proteins/genetics , Transcription, Genetic/physiology , Ubiquitin-Conjugating Enzymes/genetics , Ubiquitin-Conjugating Enzymes/metabolism , Ubiquitins/genetics , Up-Regulation/physiology
19.
J Virol ; 81(6): 2899-908, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17192311

ABSTRACT

Papillomavirus DNA replication occurs in the nucleus of infected cells and requires the viral E1 protein, which enters the nuclei of host epithelial cells and carries out enzymatic functions required for the initiation of viral DNA replication. In this study, we investigated the pathway and regulation of the nuclear import of the E1 protein from bovine papillomavirus type 1 (BPV1). Using an in vitro binding assay, we determined that the E1 protein interacted with importins alpha3, alpha4, and alpha5 via its nuclear localization signal (NLS) sequence. In agreement with this result, purified E1 protein was effectively imported into the nucleus of digitonin-permeabilized HeLa cells after incubation with importin alpha3, alpha4, or alpha5 and other necessary import factors. We also observed that in vitro binding of E1 protein to all three alpha importins was significantly decreased by the introduction of pseudophosphorylation mutations in the NLS region. Consistent with the binding defect, pseudophosphorylated E1 protein failed to enter the nucleus of digitonin-permeabilized HeLa cells in vitro. Likewise, the pseudophosphorylation mutant showed aberrant intracellular localization in vivo and accumulated primarily on the nuclear envelope in transfected HeLa cells, while the corresponding alanine replacement mutant displayed the same cellular location pattern as wild-type E1 protein. Collectively, our data demonstrate that BPV1 E1 protein can be transported into the nucleus by more than one importin alpha and suggest that E1 phosphorylation by host cell kinases plays a regulatory role in modulating E1 nucleocytoplasmic localization. This phosphoregulation of nuclear E1 protein uptake may contribute to the coordination of viral replication with keratinocyte proliferation and differentiation.


Subject(s)
Bovine papillomavirus 1/genetics , Cell Nucleus/metabolism , DNA-Binding Proteins/metabolism , Nuclear Localization Signals/genetics , Viral Proteins/metabolism , alpha Karyopherins/metabolism , Active Transport, Cell Nucleus , Animals , Bovine papillomavirus 1/growth & development , Cattle , DNA-Binding Proteins/genetics , DNA-Binding Proteins/isolation & purification , Gene Expression Regulation, Viral , HeLa Cells , Humans , Phosphorylation , Transfection , Viral Proteins/genetics , Viral Proteins/isolation & purification , alpha Karyopherins/analysis
20.
Sci STKE ; 2005(290): pe32, 2005 Jun 28.
Article in English | MEDLINE | ID: mdl-15985640

ABSTRACT

Sumoylation is a widespread posttranslational modification thought to affect primarily nuclear proteins, especially transcription factors for which sumoylation usually results in repression of their transactivational function. Recent proteomics studies have greatly expanded the cadre of known SUMO substrates, and an increasing number of cytoplasmic proteins have been identified as SUMO targets. However, very few of these cytosolic proteins have been evaluated for the functional consequences of sumoylation. Rajan et al. now demonstrate that the activity of an integral cytoplasmic membrane channel-forming protein, K2P1, is completely abrogated by sumoylation at a single lysine residue on the cytoplasmic tail. This is the first report of a plasma membrane protein as a SUMO substrate and explains the long-standing inability to demonstrate functionality of K2P1. Apparently, K2P1 is stoichiometrically sumoylated under most cellular conditions, so it is constitutively inactive until desumoylated. These observations raise several intriguing questions, including: How and where does K2P1 become sumoylated? Why, unlike most known substrates, is K2P1 so efficiently sumoylated? and, What are the signals and SUMO proteases that trigger K2P1 desumoylation? But most importantly, the report by Rajan et al. expands the functional roles attributed to sumoylation into the new arena of membrane protein functional regulation and suggests that similar mechanisms may regulate the function of other pore proteins.


Subject(s)
Potassium Channels, Tandem Pore Domain/metabolism , Protein Processing, Post-Translational , Small Ubiquitin-Related Modifier Proteins/physiology , Animals , COS Cells , Cell Membrane/metabolism , Cell Nucleus/metabolism , Chlorocebus aethiops , Cysteine Endopeptidases/physiology , Cytoplasm/metabolism , Humans , Hydrophobic and Hydrophilic Interactions , Lysine/metabolism , Potassium Channels, Tandem Pore Domain/chemistry , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Structure-Activity Relationship , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...